| Authors: |
Xie F; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Gjyrezi A; Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medical Center, New York, NY, USA., Fein D; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Labaf M; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Poluben L; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ersoy-Fazlioglu B; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Dennehy CM; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Voznesensky O; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Gad A; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Corey E; Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA., Varkaris A; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Einstein DJ; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Bhatt RS; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA., Giannakakou P; Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medical Center, New York, NY, USA. pag2015@med.cornell.edu., Balk SP; Department of Medicine, Division of Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA. sbalk@bidmc.harvard.edu. |
